1. The endocrine regulation of aging by insulin-like signals
  2. Aging and insulin secretion
  3. Mechanisms of insulin resistance in aging
  4. Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
  5. Characterization of the insulin resistance of aging.
  6. Insulin resistance with aging
  7. Glucose intolerance and aging: evidence for tissue insensitivity to insulin
  8. Insulin resistance of muscle protein metabolism in aging
  9. Insulin resistance in aging is related to abdominal obesity
  10. The insulin paradox: aging, proteotoxicity and neurodegeneration
  11. Insulin and aging
  12. Decreased cognitive function in aging non-insulin-dependent diabetic patients
  13. Insulin, aging, and the brain: mechanisms and implications
  14. Insulin regulation of heart function in aging fruit flies
  15. Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging
  16. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function
  17. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?
  18. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression
  19. Physical inactivity and obesity underlie the insulin resistance of aging
  20. Alcohol intake and insulin levels: the Normative Aging Study
  21. Contribution of visceral fat mass to the insulin resistance of aging
  22. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat.
  23. Insulin/IGF-like signalling, the central nervous system and aging
  24. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging
  25. Effects of aging on insulin secretion
  26. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease
  27. The relationship between insulin-like growth factor-I, adiposity, and aging
  28. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity
  29. Insulin-like growth factors I and II: aging and bone density in women
  30. Effect of physical training on the insulin resistance of aging
  31. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system
  32. Insulin Resistance and β-Cell Dysfunction in Aging: The Importance of Dietary Carbohydrate
  33. Insulin-like growth factor-I, cognition and brain aging
  34. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-κB signaling
  35. Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats
  36. Impact of reduced insulin‐like growth factor‐1/insulin signaling on aging in mammals: novel findings
  37. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights
  38. Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging
  39. Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study
  40. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease
  41. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review
  42. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging
  43. Methionine‐deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF‐I and insulin levels, and increases hepatocyte MIF levels and …
  44. Insulin and glucagon relationships during aging in man
  45. Insulin-like signaling, metabolism, stress resistance and aging in Caenorhabditis elegans
  46. Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity
  47. Insulin-like growth factors and aging
  48. Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence.
  49. Fetuin-null mice are protected against obesity and insulin resistance associated with aging
  50. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study
  51. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the Normative Aging Study
  52. Human growth hormone and cortisol response to insulin stimulation in aging
  53. TGF-β and insulin signaling regulate reproductive aging via oocyte and germline quality maintenance
  54. Aging and the growth hormone/insulin like growth factor-I axis
  55. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1
  56. Leucine metabolism in aging humans: effect of insulin and substrate availability
  57. Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study.
  58. The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer
  59. Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKα
  60. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals
  61. Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging
  62. Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action
  63. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction
  64. The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging
  65. Mitochondrial function, energy expenditure, aging and insulin resistance
  66. Functional implications of Drosophila insulin-like peptides in metabolism, aging, and dietary restriction
  67. Change of insulin action with aging in conscious rats determined by euglycemic clamp
  68. The role of insulin/IGF-like signaling in C. elegans longevity and aging
  69. Handgrip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study
  70. The demography of slow aging in male and female Drosophila mutant for the insulin‐receptor substrate homologue chico
  71. Activin signaling targeted by insulin/dFOXO regulates aging and muscle proteostasis in Drosophila
  72. The enteric enhancement of glucose-stimulated insulin release: the role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus
  73. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels
  74. Role of serum insulin-like growth factor I in mammalian brain aging
  75. Exercise in aging: its important role in mortality, obesity and insulin resistance
  76. Impairments in availability of insulin to liver in vivo and in binding of insulin to purified hepatic plasma membrane during aging
  77. Glucocorticoid effects on insulin-and IGF-I-regulated muscle protein metabolism during aging
  78. Estradiol, insulin-like growth factor-I and brain aging
  79. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and-3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate …
  80. Adipocyte insulin resistance: effects of aging, obesity, exercise, and food restriction
  81. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging
  82. Insulin binding to cultured human fibroblasts increases with normal and precocious aging
  83. Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats
  84. Growth hormone, insulin-like growth factor-1 and the aging brain
  85. Aging-dependent and-independent modulation of associative learning behavior by insulin/insulin-like growth factor-1 signal in Caenorhabditis elegans
  86. … serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like …
  87. The DAF‐2 insulin‐like signaling pathway independently regulates aging and immunity in C. elegans
  88. Reduction in the chondrocyte response to insulin‐like growth factor 1 in aging and osteoarthritis: studies in a non‐human primate model of naturally occurring disease
  89. Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease
  90. Relationship between changes in body composition and insulin responsiveness in models of the aging rat
  91. Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults
  92. … of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin‐1β and with chondrocyte resistance to insulin …
  93. Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin
  94. Insulin sensitivity of rat skeletal muscle: effects of starvation and aging.
  95. … decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging
  96. Influence of aging on insulin receptor binding and metabolic effects of insulin on human adipose tissue
  97. SIRT1, neuronal cell survival and the insulin/IGF-1 aging paradox
  98. … , blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging  …
  99. Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories
  100. Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination
  101. Impaired β-cell function in human aging: response to nicotinic acid-induced insulin resistance
  102. Body size, insulin/IGF signaling and aging in the nematode Caenorhabditis elegans
  103. Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention
  104. Effect of diet restriction on glucose metabolism and insulin responsiveness in aging rats
  105. The nature of insulin secretory defect in aging rats
  106. Insulin regulates aging and oxidative stress in Anopheles stephensi
  107. Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats
  108. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging
  109. Aging is associated with resistance to effects of leptin on fat distribution and insulin action
  110. Differential effects of aging and insulin-like growth factor-1 on synapses in CA1 of rat hippocampus
  111. Temporal relations between obesity and insulin: longitudinal data from the Normative Aging Study
  112. Growth hormone, insulin and aging: the benefits of endocrine defects
  113. Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function
  114. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues
  115. Human aging is associated with parallel reductions in insulin and amylin release
  116. Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort
  117. Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling
  118. Insulin exposure and aging theory
  119. The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy
  120. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans
  121. In Vivo Insulin-Dependent Glucose Uptake of Specific Tissues Is Decreased during Aging of Mature Wistar Rats
  122. Does aging intensify the insulin resistance of human obesity?
  123. Aging and insulin secretion
  124. Effects of aging and dietary restriction on tissue protein synthesis: relationship to plasma insulin-like growth factor-1
  125. Insulin-like growth factor-1 in CNS and cerebrovascular aging
  126. Aging-associated insulin resistance predisposes to hypertension and its reversal by exercise: the role of vascular vasorelaxation to insulin
  127. Oxidative stress contributes to aging by enhancing pancreatic angiogenesis and insulin signaling
  128. Insulin-like growth factors (IGFs): implications for aging
  129. Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging
  130. Increased Susceptibility to Insulin Resistance Associated with Abdominal Obesity in Aging Rats**
  131. Glucose and amino acid metabolism in aging man: differential effects of insulin
  132. Reduced brain insulin-like growth factor I function during aging
  133. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I
  134. … on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging
  135. Essential role of protein tyrosine phosphatase 1B in obesity‐induced inflammation and peripheral insulin resistance during aging
  136. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate
  137. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage
  138. Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation
  139. Insulin action in aging man: Evidence for tissue-specific differences at low physiologic insulin levels
  140. Influence of adiposity in the blunted whole-body protein anabolic response to insulin with aging
  141. Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction
  142. Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart
  143. Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance
  144. Role of impaired intracellular glucose metabolism in the insulin resistance of aging
  145. Mitochondrial function and insulin resistance during aging–a mini-review
  146. Metabolic triad in brain aging: mitochondria, insulin/IGF-1 signalling and JNK signalling
  147. Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes
  148. Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-Sponsored Symposium
  149. Oxidative aging and insulin receptor signaling
  150. Articular chondrocytes from aging rats respond poorly to insulin-like growth factor-1: an altered signaling pathway
  151. Chronic 17β-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging
  152. Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: progress and controversies
  153. Growth hormone induces somatostatin and insulin-like growth factor I gene expression in the cerebral hemispheres of aging rats
  154. Insulin Growth Factor‐I Inhibits Apoptosis in Hematopoietic: Progenitor Cells Implications in Thymic Aginga
  155. A possible role for insulin in the altered capability for hepatic enzyme adaptation during aging
  156. The paradox of neuronal insulin action and resistance in the development of aging-associated diseases
  157. Insulin is differentially related to cognitive decline and atrophy in Alzheimer’s disease and aging
  158. Impaired ventilatory function and elevated insulin levels in nondiabetic males: the Normative Aging Study
  159. MCH−/− mice are resistant to aging-associated increases in body weight and insulin resistance
  160. LET‐60 RAS modulates effects of insulin/IGF‐1 signaling on development and aging in Caenorhabditis elegans
  161. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback
  162. Insulin resistance and aging: a cause or a protective response?
  163. Which anthropometric indices of regional adiposity are related to the insulin resistance of aging?
  164. Altered regulation of insulin secretion in isolated islets of different sizes in aging rats
  165. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging
  166. Regulation of excitation contraction coupling by insulin-like growth factor-1 in aging skeletal muscle.
  167. Hostility and urine norepinephrine interact to predict insulin resistance: the VA Normative Aging Study
  168. Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging
  169. Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular disease
  170. Appendicular skeletal muscle mass and insulin resistance in an elderly Korean population: the Korean social life, health and aging project-health examination …
  171. Insulin receptor kinase activity in rat adipocytes is decreased during aging
  172. Diet, not aging, causes skeletal muscle insulin resistance
  173. Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes
  174. Interaction of multiplication stimulating activity/rat insulin-like growth factor II with skeletal muscle satellite cells during aging
  175. … gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat …
  176. Insulin receptors in the brain cortex of aging mice
  177. Aging enhances the insulin resistance in obesity through both receptor and postreceptor alterations
  178. Training-induced enhancement of insulin action in human skeletal muscle: the influence of aging
  179. Targeted disruption of inducible nitric oxide synthase protects against aging, S-nitrosation, and insulin resistance in muscle of male mice
  180. Intranasal insulin improves age-related cognitive deficits and reverses electrophysiological correlates of brain aging
  181. Changes in insulin receptor kinase with aging in rat skeletal muscle and liver
  182. Changes in protein, carbohydrate, and fat metabolism with aging: possible role of insulin
  183. Tissue‐specific insulin signaling in the regulation of metabolism and aging
  184. Effect of age and caloric restriction on insulin receptor binding and glucose transporter levels in aging rats
  185. Adipose tissue-derived tumor necrosis factor activity correlates with fat cell size but not insulin action in aging rats
  186. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study
  187. The role of the glucose transport system in the postreceptor defect in insulin action associated with human aging
  188. Metallothionein antagonizes aging‐induced cardiac contractile dysfunction: role of PTP1B, insulin receptor tyrosine phosphorylation and Akt
  189. Modulation of SIRT1-Foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance
  190. Caloric restriction and insulin-like growth factors in aging and cancer
  191. Insulin exposure controls the rate of mammalian aging
  192. Aging and insulin resistance in a group of nonobese male volunteers
  193. The endothelium abridges insulin resistance to premature aging
  194. Metabolic effects of resveratrol in mammals-a link between improved insulin action and aging
  195. Effect of gender on insulin resistance associated with aging
  196. Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes
  197. Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: novel protective role of glutathione
  198. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin‐like growth factor 1 and osteogenic protein 1
  199. Influence of cardiac‐specific overexpression of insulin‐like growth factor 1 on lifespan and aging‐associated changes in cardiac intracellular Ca2+ homeostasis …
  200. Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis
  201. Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR …
  202. β cell aging markers have heterogeneous distribution and are induced by insulin resistance
  203. Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8)
  204. Dissociation between metabolic and vascular insulin resistance in aging
  205. Aging and Restriction of Dietary Calories Increases Insulin Receptor mRNA, and Aging Increases Glucocorticoid Receptor MRNA in the Liver of Female C3B10RF1 …
  206. Method of treating reduced insulin-like growth factor and bone loss associated with aging
  207. Regulation of insulin receptor mRNA splicing in rat tissues: effect of fasting, aging, and diabetes
  208. The ubiquitin ligase CHIP integrates proteostasis and aging by regulation of insulin receptor turnover
  209. Secretion of insulin during aging
  210. Aging is associated with elevated muscle triglyceride content and increased insulin-stimulated fatty acid uptake
  211. Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen
  212. Regulation of insulin secretion by glucose during aging
  213. Effect of aging on insulin secretory function and expression of beta cell function-related genes of islets
  214. Insulin Release in Aging: Dynamic Response of Isolated Islets of Langerhans of the Rat to D-Glucose and D-Glycer aldehyde
  215. Serum insulin‐like growth factor‐1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study
  216. Relationships between insulin-like growth hormone factor-I and estradiol in reproductive aging
  217. Loss of postprandial insulin sensitization during aging
  218. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity
  219. Longevity pathways (mTOR, SIRT, Insulin/IGF-1) as key modulatory targets on aging and neurodegeneration
  220. Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging
  221. The effect of aging on insulin signalling pathway is tissue dependent: central role of adipose tissue in the insulin resistance of aging
  222. Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats
  223. Effects of epinephrine on insulin secretion and action in humans: interaction with aging
  224. Restorative effect of intracerebroventricular insulin-like growth factor-I gene therapy on motor performance in aging rats
  225. Effects of aging on insulin synthesis and secretion. Differential effects on preproinsulin messenger RNA levels, proinsulin biosynthesis, and secretion of newly made …
  226. Increased expression of type 1 insulin-like growth factor receptor messenger RNA in rat hippocampal formation is associated with aging and behavioral impairment
  227. Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: from yeast to the mammalian brain
  228. Aging and insulin resistance: just say iNOS
  229. … and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin …
  230. Aging per se increases the susceptibility to free fatty acid–induced insulin resistance
  231. Aging and insulin sensitivity: role of blood pressure and sympathetic nervous system activity
  232. Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer’s disease
  233. L-type Ca2+ channel-insulin-like growth factor-1 receptor signaling impairment in aging rat skeletal muscle
  234. Rats with low brain angiotensinogen do not exhibit insulin resistance during early aging
  235. Insulin-like growth factor-1 stimulation of protein synthesis is attenuated in cerebral cortex of aging rats
  236. Insulin-like growth factor-I receptor densities in human frontal cortex and white matter during aging, in Alzheimer’s disease, and in Huntington’s disease
  237. Serum levels of insulin‐like growth factor 1 in subjects with osteoarthritis of the knee. Data from the baltimore longitudinal study of aging
  238. Parental imprinting regulates insulin-like growth factor signaling: a Rosetta Stone for understanding the biology of pluripotent stem cells, aging and …
  239. From lipodystrophy and insulin resistance to metabolic syndrome: HIV infection, treatment and aging
  240. Aging does not contribute to the decline in insulin action on storage of muscle glycogen in rats
  241. Glucose intolerance and insulin resistance with aging—studies on insulin receptors and post-receptor events
  242. Aging is associated with myocardial insulin resistance and mitochondrial dysfunction
  243. … disruption of spermidine/spermine N1‐acetyltransferase gene maintain nearly normal tissue polyamine homeostasis but show signs of insulin resistance upon aging
  244. Synthesis-secretion coupling of insulin: effect of aging.
  245. … metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer’s disease …
  246. Effect of aging on the expression of peroxisome proliferator-activated receptor γ and the possible relation to insulin resistance
  247. Heat shock factor-1 intertwines insulin/IGF-1, TGF-β and cGMP signaling to control development and aging
  248. Insulin exposure and unifying aging
  249. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity
  250. Dexamethasone-induced insulin resistance and pancreatic adaptive response in aging rats are not modified by oral vanadyl sulfate treatment
  251. Insulin release in aging: studies on adenylate cyclase, phosphodiesterase, and protein kinase in isolated islets of Langerhans of the rat
  252. Effect of aging on the kinetic characteristics of the insulin receptor autophosphorylation in rat adipocytes
  253. Short-term estradiol administration in aging ovariectomized rats provides lasting benefits for memory and the hippocampus: a role for insulin-like growth factor-I
  254. DAF-2/insulin-like signaling in C. elegans modifies effects of dietary restriction and nutrient stress on aging, stress and growth
  255. Insulin‐like growth factor‐I gene therapy increases hippocampal neurogenesis, astrocyte branching and improves spatial memory in female aging rats
  256. Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow
  257. Dietary (−)-Epigallocatechin-3-gallate supplementation counteracts aging-associated skeletal muscle insulin resistance and fatty liver in senescence-accelerated …
  258. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases
  259. Post-developmental microRNA expression is required for normal physiology, and regulates aging in parallel to insulin/IGF-1 signaling in C. elegans
  260. Development of insulin resistance during aging: involvement of central processes and role of adipokines